BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 25749206)

  • 1. Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring.
    Telo GH; Volkening LK; Butler DA; Laffel LM
    Diabetes Technol Ther; 2015 Jun; 17(6):373-8. PubMed ID: 25749206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Youth and parent measures of self-efficacy for continuous glucose monitoring: survey psychometric properties.
    Rasbach LE; Volkening LK; Markowitz JT; Butler DA; Katz ML; Laffel LM
    Diabetes Technol Ther; 2015 May; 17(5):327-34. PubMed ID: 25695341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes.
    McGill DE; Volkening LK; Butler DA; Harrington KR; Katz ML; Laffel LM
    Diabetes Technol Ther; 2018 Jun; 20(6):434-439. PubMed ID: 29727245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Glucose Monitoring Associated With Less Diabetes-Specific Emotional Distress and Lower A1c Among Adolescents With Type 1 Diabetes.
    Vesco AT; Jedraszko AM; Garza KP; Weissberg-Benchell J
    J Diabetes Sci Technol; 2018 Jul; 12(4):792-799. PubMed ID: 29595061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type.
    Franceschi R; Pertile R; Marigliano M; Mozzillo E; Maffeis C; Morotti E; Di Candia F; Fedi L; Iafusco D; Zanfardino A; Cauvin V; Maltoni G; Zucchini S; Cherubini V; Tiberi V; Minuto N; Bassi M; Rabbone I; Savastio S; Tinti D; Tornese G; Schiaffini R; Passanisi S; Lombardo F; Bonfanti R; Scaramuzza A; Troncone A
    Diabet Med; 2024 Jun; 41(6):e15307. PubMed ID: 38383984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.
    Berg AK; Nørgaard K; Thyssen JP; Zachariae C; Hommel E; Rytter K; Svensson J
    Diabetes Technol Ther; 2018 Jul; 20(7):475-482. PubMed ID: 29893593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers.
    Commissariat PV; Boyle CT; Miller KM; Mantravadi MG; DeSalvo DJ; Tamborlane WV; Van Name MA; Anderson BJ; DiMeglio LA; Laffel LM
    Diabetes Technol Ther; 2017 Jun; 19(6):363-369. PubMed ID: 28581817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
    Patton SR; Noser AE; Youngkin EM; Majidi S; Clements MA
    Diabetes Technol Ther; 2019 Jul; 21(7):379-384. PubMed ID: 31166808
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
    Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
    Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes.
    Rasbach LE; Atkins AE; Milaszewski KM; Keady J; Schmidt LM; Volkening LK; Laffel LM
    J Diabetes Sci Technol; 2014 May; 8(3):494-7. PubMed ID: 24876612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics.
    Lawson ML; Bradley B; McAssey K; Clarson C; Kirsch SE; Mahmud FH; Curtis JR; Richardson C; Courtney J; Cooper T; Downie CJ; Rajamannar G; Barrowman N; ;
    BMC Pediatr; 2014 Jul; 14():183. PubMed ID: 25034216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study.
    Sheikh K; Bartz SK; Lyons SK; DeSalvo DJ
    J Diabetes Res; 2018; 2018():5162162. PubMed ID: 30151393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial.
    Lawson ML; Verbeeten KC; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Chan J; Tang K
    Pediatr Diabetes; 2021 Mar; 22(2):279-287. PubMed ID: 33098212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes.
    Diabetes Research in Children Network (DirecNet) Study Group
    Pediatr Diabetes; 2006 Feb; 7(1):32-8. PubMed ID: 16489972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
    ; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K
    Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.